Jian Li, C. Rayner, R. Nation
Nov 1, 2005
Citations
4
Influential Citations
130
Citations
Quality indicators
Journal
Antimicrobial Agents and Chemotherapy
Abstract
Intravenous colistin methanesulfonate (CMS) is increasingly the last line of defense for multidrug-resistant gram-negative bacteria and is now being used as “salvage” therapy in critically ill patients ([1][1], [7][2], [9][3], [11][4]). CMS is converted in vivo to colistin, and these two